Both in Pharmaceuticals
InMed Pharmaceuticals vs Actinium Pharmaceuticals
Over the past year INM returned +405.8% and ATNM returned +4.4%; their daily moves had a correlation of 0.01.
INM +405.8% ATNM +4.4%Growth of $1, one year, split-adjusted
| Metric | INM | ATNM |
|---|---|---|
| Price | $8.75 | $1.41 |
| Market cap | $48.1M | $44.3M |
| Today | +420.83% | +0.71% |
| 1 month | +557.9% | +27.0% |
| 6 months | +1104.6% | +13.7% |
| Year to date | +725.5% | +3.7% |
| 1 year | +373.0% | +2.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | 79.7% |
| P/E (TTM) | — | 3.9× |
| Price / sales | 24.8× | 1.3× |
| Net cash | $2.2M | $36.5M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 90.5% |
| Short % of float | 0.1% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).